P831: PATIENT-REPORTED OUTCOMES IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH CROVALIMAB: RESULTS FROM THE COMPOSER TRIAL

por Röth, A., Panse, J., Gentile, B., Buri, M., Patel, H., Nagy, Z.
Publicado 2022

P830: CROVALIMAB MAINTAINS CLINICAL BENEFIT OVER LONG-TERM TREATMENT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RESULTS FROM THE COMPOSER TRIAL OPEN-LABEL EXTENSION

por Röth, A., Egyed, M., Ichikawa, S., Ito, Y., Kim, J. S., Nagy, Z., Obara, N., Panse, J., Schrezenmeier, H., Sica, S., Soret, J., Usuki, K., Yoon, S.-S., Benkali, K., Buri, M., Lundberg, P., Patel, H., Shinomiya, K., Sreckovic, S., Nishimura, J.-I.
Publicado 2022